© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Japanese scientist Hamao Umezawa shook up the antibiotic world in 1957 with the discovery of kanamycin. At that point, tuberculosis and resistant Gram-negative infections shook communities, and treatment options hit a wall. Derived from Streptomyces kanamyceticus, this compound quickly earned its stripes as a blow to stubborn infections. Over time, its salts, including kanamycin disulfate, emerged to boost handling, stability, and compatibility in pharmaceutical production and research. By the late 20th century, the focus started to shift: clinicians and researchers kept an eye on resistance trends and sought safer dosing. Generations of microbiologists grew up working with kanamycin and its salts in labs everywhere; I’ve watched agar plates dotted with colonies reveal which bugs surrendered to its punch, and which dug in with resistance genes.
Kanamycin disulfate takes the core antibiotic and stabilizes it in a sulfate salt form, which presents as a white to off-white crystalline powder—an approachable substance for hospital pharmacies and research benches. It stands out for halting bacterial protein synthesis, gumming up the ribosomal machine right at the source. The sulfate version brings better solubility in water and smoother integration into injectable formulations, as well as media cocktails poured daily in gene-editing labs. It’s the go-to when precision matters—whether stopping an infection in its tracks or creating selective pressure in E. coli transformation protocols. The substance earns a listing on the World Health Organization’s list of essential medicines, and international standards demand traceable purity and consistent manufacturing for every lot.
On the lab bench, kanamycin disulfate powder gives off no odor, but its impact gets noticed fast. Chemically, it carries the formula C18H36N4O13 · H2SO4, giving it a molar mass that tips the scales at over 582 g/mol. Readings under the microscope show clean, fine crystals. Toss it in water and it dissolves fast, but you’ll miss that with alcohol or nonpolar solvents. The molecule bristles with amino and hydroxyl groups, feeding into both its activity and its vulnerability to involved chemical reactions. Throw a UV lamp its way, and researchers can check identity through characteristic absorbance—another handy tool during quality control.
Pharma and research suppliers set strict bars here: not less than 900 micrograms of base per milligram, dryness below 2%, and bacterial endotoxins kept far below set exposure thresholds. Vial labels must call out batch numbers, expiry dates, clear storage conditions (preferably two to eight degrees Celsius, away from light), and always warn about proper disposal. I’ve worked with certified reference standards for kanamycin disulfate, and seeing a supplier’s Certificate of Analysis detailing microbial and chemical purity counts as the green light for legitimate research. Auditors comb through documentation, so companies need transparent batch traceability and alignment with USP, EP, and JP monographs.
Industrial production begins with a culture of Streptomyces kanamyceticus bubbling away in a nutrient fermenter. After incubation, downstream processing extracts and purifies the antibiotic, which then undergoes salt formation by reaction with sulfuric acid in controlled reactors. Purification runs deep, with repeated crystallization, washing, and filtration steps picking off impurities. Final freeze-drying or vacuum drying grabs a powder that resists moisture and spoiling. From there, strict QC analysis checks purity, crystal structure, and stability—labs can’t afford uncertainties or misleading results when patient care or DNA manipulation rides on dosage accuracy.
Kanamycin disulfate suits chemical modification, thanks to multiple free amino and hydroxyl positions. Medicinal chemists tinker with these sites to generate derivatives like amikacin, which can leapfrog certain resistant bacterial strains. Lab techniques harness the molecule in conjugation protocols—adding biotin, fluorophores, or other tags for tracking antibiotic movement or for developing sensor assays. Exposure to acidic or basic media can cleave sensitive bonds, so researchers and manufacturers lock down process environments to avoid degradation. Redox chemistry using sulfhydryl crosslinkers also taps its potential in drug-delivery innovation and affinity labeling. These modifications push the antibiotic into new therapeutic or analytical frontiers.
Across the globe, kanamycin disulfate answers to several names: Kanamycin Monosulfate, Kanamycin A Sulfate, and Kanamycin Sulphate. In pharma catalogs, labels often also include the word “antibiotic” or highlight the salt form for clarity. Upstream regulatory documents and patents trace its trail through these synonyms, even as scientists debate subtle distinctions in salt content or hydration state. Anyone working in procurement or regulatory compliance learns these names fast, since one typo or missed synonym can hang up supply chains or trigger an audit.
Every contact with kanamycin disulfate calls for respect as a hazardous substance. Skin exposure, eye contact, or inhalation can spark allergic responses, and handling the dry powder without gloves or masks carries real risk for lab and plant staff. Workplace protocols set sharp boundaries: powder manipulation under vented hoods, meticulous surface decontamination, and restricted access to storage areas. Disposal guidelines classify the compound alongside other cytotoxic or antimicrobial agents, with incineration or chemical neutralization expected. Training goes beyond box-ticking—colleagues and trainees need to hear about ototoxic and nephrotoxic effects, even from seemingly casual splashes or spills. My experience has taught that shortcuts on personal protective equipment always catch up, as even small amounts can linger on gloves or bench tops.
Hospital wards and clinics have counted on kanamycin disulfate as a reserve weapon against drug-resistant tuberculosis and Gram-negative infections, especially in areas where no newer options hold up. Yet concerns about toxicity, particularly damage to hearing and kidneys, have tempered enthusiasm for routine clinical use. Researchers continue to favor the sulfate salt in molecular biology, where it draws genetic selection lines in bacterial culture. For every CRISPR edit or positive transformant, kanamycin plates separate engineered cells from the crowd. Plant science trials integrate the antibiotic for the same purpose—granting only genetically modified lines the resilience to grow in selective environments. Veterinary medicine takes a cautious approach, balancing therapeutic gains against three R’s (resistance, residue, regulation). The antibiotic carves out a core niche in diagnostic assays, reference testing, and bio-manufacturing models as well.
University and pharma labs pour time and resources into understanding the mechanisms that drive bacterial resistance to kanamycin and its relatives. Genetic sleuthing tracks the mobile resistance genes, like those encoding aminoglycoside-modifying enzymes or ribosomal mutations, sometimes spreading silently through rural hospitals. Development pipelines stretch into derivatives keyed to bypass such resistance blocks, chase lower toxicity, or sharpen target precision. Collaborative programs team up microbiologists, chemists, and clinicians, with growing momentum for data-sharing and genomic surveillance. Platforms such as PubChem, KEGG, and global AMR initiatives log findings that shape both current practice and long-range planning. After years in the trenches, I’ve seen more doctoral theses and postdoc projects written on kanamycin resistance pathways than on nearly any other single antibiotic.
What lands kanamycin disulfate on restricted lists for many indications is the real risk of permanent hearing loss and kidney damage, particularly in high-dose regimens or in patients with previous vulnerabilities. Decades of clinical studies build the evidence: ototoxicity can strike unpredictably, with children and the elderly most at risk. Early animal models and modern cell studies both track damage to cochlear hair cells and renal tubular epithelium, mapping out dose-response curves, genetic susceptibilities, and possible antioxidants for protective effects. Though newer antibiotics carry better safety profiles, resource-limited settings still return to kanamycin in desperate times. Risk communication stays central—clinicians require blunt data on duration, dose, and risk factors. Pharmacovigilance data and meta-analyses keep building a case for conservative use, close monitoring, and patient engagement in treatment choices. My time in outreach has driven home the challenge: communities remember stories of ototoxicity disasters far longer than scientific journal headlines.
The road ahead for kanamycin disulfate runs through changing landscapes of resistance, stewardship, and synthetic biology. Its clinical shelf life shrinks in the face of resistant bacteria spreading faster than effective new drugs arrive. At the same time, biotechnologists continue to rely on its selective power in genetic engineering work, optimizing protocols and novel vectors to push the boundaries of what engineered microbes can do. Innovation circles back: research into kanamycin analogs, combination therapies, or delivery systems (like liposomes or microneedle patches) aims to stretch the value of its core mechanism. Regulations will only tighten, especially with updates from the World Health Organization and food safety authorities on antimicrobial residues and environmental impact. I’ve learned through years of handling drug documentation and field work that real progress depends on blending smart science with responsible policy. That lens will decide whether kanamycin disulfate stays as a relic or evolves into a tool for new scientific and medical breakthroughs.
Ask someone who’s spent time in a microbiology lab what’s sitting in the refrigerator, and kanamycin disulfate often makes the list. For decades, this antibiotic has helped both doctors and scientists tackle tough challenges. I remember my own lab days—kanamycin stocks lined up next to the agar plates—serving as a quiet, reliable hammer against bacteria that would otherwise spoil an entire experiment.
Doctors still reach for kanamycin disulfate in hospitals, especially with infections that laugh at older antibiotics. Tuberculosis, for example, brings a fierce battle to the lungs. In cases where the microbe shrugs off front-line medicines, kanamycin comes into play. The World Health Organization recognizes kanamycin for use against resistant strains. Still, it’s not a gentle drug—a patient’s kidneys and ears both need careful monitoring.
I’ve watched infectious disease teams agonize over these choices. They weigh risks versus benefits with every dose. Kanamycin isn’t a first pick, but when the choices grow thin, it’s a crucial backup. Reports from the CDC stress this reality too—antibiotic resistance doesn’t just threaten tomorrow’s patients; it hits clinics today.
Beyond medicine, kanamycin’s story carries on in research. Every summer, undergraduate interns—and more than a few seasoned post-docs—prepare petri dishes with kanamycin. It does more than block bacterial growth; it helps sort out which cells took up the right DNA. If you want to insert a new gene into E. coli, kanamycin resistance genes offer a reliable screening tool. Cells that grow in its presence likely have the DNA you need.
This simple method has fueled everything from making insulin with bacteria to testing genetic theories. Without antibiotics like kanamycin, modern biotechnology looks very different. I spent frustrated evenings watching plates in the incubator, hoping the colonies growing overnight carried my genetic insert. Without a marker like kanamycin, tracking success feels like looking for a needle in a haystack.
Potent antibiotics carry risk. Resistance can spread quickly—whether in clinics or research facilities. In hospitals, stewardship programs track every dose. In research, best practices call for careful disposal and strict protocols. The risks aren’t small; careless handling can breed “superbugs” that shrug off kanamycin, leaving fewer tools in the medical arsenal.
Fact: A 2022 review in the journal Antibiotics highlighted that overuse and mishandling in all settings, even in labs, speed up resistance. Having worked with infection control teams, I’ve seen how vital continued training and vigilance stay, both at the bench and bedside. Smart policies support the careful use of these compounds and discourage unnecessary exposure.
The world relies on antibiotics like kanamycin disulfate for both healing and discovery. Policymakers, clinicians, and researchers need to keep working together. Developing newer, safer alternatives helps. So does spreading knowledge about careful handling and honest risk assessment. My own experience says that antibiotics, wielded wisely, remain a foundation of science and medicine—but they demand respect, not routine use. As more people understand this balance, healthcare and research stand a stronger chance against today’s toughest microbes.
Anyone who’s worked with antibiotics like Kanamycin Disulfate knows these substances don’t just sit on a shelf without a care in the world. It's all too easy to ruin a whole batch by playing fast and loose with storage. This antibiotic plays a big role in both hospital pharmacies and research labs, so storing it right can be the difference between a successful experiment or clinical intervention and a frustrating failure.
Kanamycin Disulfate belongs to the aminoglycoside family, so it shares some traits with other compounds in the group. Leaving it exposed to high temperatures or wild humidity swings shortens its shelf life. Pharmacies and lab techs usually keep it in a dry, refrigerated room—straightforward, but not always as easy as it sounds. The sweet spot for storage lives at 2–8°C (36–46°F), best achieved by sticking it in a reliable refrigerator. Nobody wants to open a bottle and find out the powder has turned into a brick or that contamination crept in. Keeping moisture low just makes sense, so stick with those desiccant packs that come with the shipment.
I remember a mishap during my first summer internship in a genetics lab. Someone left the fridge door open. That simple mistake wasted $800 worth of antibiotics. Since then, I keep a thermometer in the fridge and always close that door, because consistency means everything. You don’t want one corner freezing and another getting too warm.
If you’ve handled antibiotics long enough, stories about batch failures pop up at every coffee break. Light degrades Kanamycin Disulfate, so keeping containers tightly sealed and out of direct fluorescent bulbs helps. Once, I watched a tech pour from one bottle to another right under a lamp, just because the light was better. He regretted it. Most containers arrive amber-tinted or opaque, since blocking light preserves strength. Never transfer to clear vials if you can avoid it.
Exposure to air isn’t much better. The powder pulls moisture from the air, forming clumps and losing punch. Every time the lid comes off, keep it quick. Open it up in a clean, dry spot and never leave scoops or spatulas inside after measuring. If the original bottle seals tight, use it as long as you can instead of moving the powder around.
Trust me, labels matter. Temperature guidelines and expiration dates deserve prime real estate on whatever bottle you use. In one crowded research fridge, unlabeled tubes can get mixed up or forgotten in the shuffle, which wastes precious time and money. Many labs run periodic checks by pulling every bottle of Kanamycin Disulfate, looking for expiration dates and signs of damage. Powder that changes color, shows crystals, or smells off goes straight into the drug disposal bin without a second thought.
Short power outages don’t always get reported, especially on weekends. Remote sensors or digital thermometers that send alerts to your phone can catch these early, saving an entire stock. For hospitals stocking large amounts, backup generators or separate fridges for antibiotics provide insurance against costly spoilage. If resources run thin, team up with nearby labs to borrow space or run temperature checks together. Small changes like these go a long way in protecting both pocketbooks and patients.
Good science and safe medicine both start with those small, behind-the-scenes details. Temperature, dryness, tight seals, and good labeling all matter. A little care upfront means Kanamycin Disulfate stays as effective in the last test as it did in the first.
Anyone who’s ever worked in a lab knows sloppy prep leads to messy results. Kanamycin Disulfate, like any antibiotic, needs careful handling. I learned this after watching a colleague lose a whole week’s worth of plates to contamination. That taught me to double-check everything before getting started.
Every batch of Kanamycin Disulfate comes with a label and a lot number. It’s tempting to skip the fine print. Big mistake. Concentration, storage suggestion, and expiration date dictate how you measure and weigh it. Relying on memory doesn’t cut it. The difference between 50 and 100 milligrams per milliliter means hitting your bacteria with a knockout punch or letting resistant colonies through. I found it good practice to always cross-check vendor documentation before measuring out the powder.
An autoclave and a clean beaker go further than any fancy new piece of equipment. I start with sterile distilled water. Regular tap water might seem good enough, but I’ve seen what happens when you skip the sterile step. Once, we found filamentous fungi growing in what should have been a bacterial-only plate.
I usually add powder slowly, stirring to help it dissolve. Kanamycin Disulfate mixes best at room temperature. Heating to make it dissolve faster doesn’t help—the antibiotic breaks down and won’t do its job. Persistence pays off. Stir until nothing's left at the bottom. Solution clarity tells you it’s mostly ready.
In our lab, a common stock is 50 mg per milliliter. I rely on an accurate scale—no guesswork. Ask anyone who’s had to repeat a transformation because of under-dosing, and they’ll tell you it’s worth the extra time measuring twice.
This concentration keeps the work consistent. Most academic papers recommend it for cloning and selection steps. Hospitals tend to use far less, but selection pressure in plates needs that punch to be effective.
Once dissolved, filtration comes next. I always use a 0.22-micron filter. All sorts of bacteria can hide in tap water or cling to flask walls. I’ve seen growth in ‘sterile’ supplements that were just hastily dissolved powder.
I ran a side-by-side test—one filtered, one not—and the difference jumped out after overnight incubation. Cloudy growth told its story. Skip filtration, and everything downstream becomes suspect.
I label every tube with a Sharpie, add the date, and keep it in the freezer. Light breaks down this antibiotic. So, I wrap every tube in foil. After a few weeks, I pitch any old stock. Using old or degraded antibiotic once cost me precious engineered strains. A freezer that cycles above zero means trouble. Monitoring temperature saves headaches later.
If plates show no growth, check the math and the date. If too much growth appears, expect contamination or not enough Kanamycin. Running a simple positive and negative control experiment usually helps pinpoint the mistake. I’ve learned that even just double-checking all prep steps cuts down troubleshooting by half.
Kanamycin Disulfate won’t forgive shortcuts. Care in weighing and measuring, using clean water, filtering the final solution, and handling storage properly keep experiments running smoothly.
Kanamycin Disulfate stays useful for several years if sealed tight and stored away from light and moisture. Scientists, pharmacists, and lab workers rely on its stability to keep experiments accurate and patient care safe. Most vials or powdered forms carry an expiration date set for about three years after manufacture. This shelf life isn’t just a guess—manufacturers use real-time stability studies and guidelines drawn from research to set these limits. Temperature and humidity swing the odds either direction: keep it cool and dry, you keep it alive; let air or sunlight at it, you reduce its punch.
Drugs like Kanamycin Disulfate aim to kill bacteria; their effectiveness drops if the chemical structure changes over time. Past that date stamped on the bottle, breakdown creeps in and the product stops hitting harmful organisms the way it should. I’ve seen older antibiotics lose their bite or even spark unintended side effects as unfamiliar breakdown products form.
I once ran into this on a late-night shift with a science team facing an urgent outbreak. Some labs had an expired stock of Kanamycin Disulfate. The temptation to cut corners and use what’s on hand can pop up, especially for rare supplies. But risking uncertain potency can backfire, leading to incomplete treatments or false lab data. Decisions based on weak antibiotics can delay recovery and feed resistance in bacteria—a threat already on the rise.
The U.S. Pharmacopeia and the World Health Organization both push for tight adherence to expiration guidelines. Kanamycin Disulfate powder, kept dry and at room temperature, usually keeps its structure for 24–36 months after production. That keeps researchers and clinicians on track to deliver reliable results. Once a container opens, exposure to humidity speeds up breakdown, shaving time off the viable shelf life. Lab manuals I trust recommend logging the opening date and, if possible, moving the powder to sealed containers with desiccant packs.
Manufacturers test batches at various temperatures and levels of moisture to set those shelf lives. They publish data, so anyone ordering this antibiotic can see documents confirming that three-year window. That boosts confidence and transparency, key parts of E-E-A-T principles that keep patient care, research, and safety in line with best practices.
Drug storage doesn’t get much glory in science or medicine, but it touches every good result or successful treatment. Put Kanamycin Disulfate in a cool, dry cabinet, away from direct sunlight. Keep lids tightly closed. Never scoop out what you need above open containers, since moisture in the air makes its way in fast. Old or expired product never belongs in regular trash or washed down the drain—local regulations call for returns, safe incineration, or specialized take-back programs. A clear system for labeling, tracking expiration, and safe disposal avoids surprises and keeps the whole operation above board.
I’d like to see wider adoption of digital tracking for chemical inventories. Barcodes and automatic reminders for expiring stock can save time and cut waste. Increasing storage training for new lab techs and pharmacists could also make a real difference: many times, mistakes come from simple habit or oversight, not lack of knowledge. Teams that check shelves every quarter spend less money and keep results consistent. Better packaging with stronger seals or desiccant-lined bottles could stretch the useful life even further, especially for groups with irregular supply chains.
Anyone who’s spent time in a biology lab knows the role antibiotics like kanamycin disulfate play. Adding them to growth media lets researchers tell the transformed from the untransformed and quickly spot where their insert landed. Kanamycin’s strength lies in its ability to wipe out non-resistant strains, giving those carrying the resistance gene free rein to grow. The trick is finding a dose that works without taking out everything in the dish, including the cells you want.
Most of the textbooks and protocol guides I’ve worked with settle on a starting concentration of 50 micrograms per milliliter (µg/mL) for kanamycin disulfate in LB agar or broth. Some teams go as low as 25 µg/mL; others push it higher, maybe 100 µg/mL, for certain stubborn strains. People working with highly sensitive strains don’t always need as much, but most E. coli used for cloning are pretty standard. That 50 µg/mL mark comes from decades of scientists comparing notes and tracking colony growth.
A weaker dose risks letting background colonies sneak through, which can waste entire days in the lab. I’ve run plates with only 20 µg/mL kanamycin to see if I could cut costs, and the false positives piled up, robbing quality checks and transforming every step into a guessing game. On the other side, overdosing can create slow growers or even wipe out your treasured transformants. This matters when working with especially delicate constructs or library screens where every survivor could mean a breakthrough.
Temperature, media richness, and even the actual kanamycin batch can stir the results. One batch might make bacteria look like they’re growing in slow motion, while another produces crispy, clear-cut selection. Nutrient levels in the agar or broth influence how fast bacteria metabolize the drug and may affect resistance. My own plates grew best on fresh kanamycin stocks—waiting even a few days in light and warmth, I watched potency fade. Stories from the field back up the advice: dissolve it fresh at 10 mg/mL stock, filter sterilize it, and keep it dark and cool.
Ampicillin gets talked up for its sensitivity to degradation, but kanamycin isn’t immune. The more care you give preparation, the more reliable your selections. I’ve watched seasoned postgraduates double-check freezer temperatures and whether media had been sitting out longer than planned. These small habits add up; skipping a step often leads to wasted effort, plates full of contamination, and frustration you remember long after the experiment.
It’s not just about picking an amount from a manual. It helps to test a new strain at a lower and a higher concentration on test plates, then see where the growth falls off. Saving time up front with a quick check means smoother days down the line. For labs running high-throughput screens or transforming rare plasmids, meticulous preparation has big payoffs. Reliable antibiotic selection keeps the scientific process on track—no one wants extra cloning steps just because a concentration got rounded too far.
I’ve seen labs set up comparison plates to calibrate batches, tracking each detail in a logbook so the next team doesn’t have to guess. Respecting the history of those who went before—using established concentrations and watching for small changes—maximizes both results and peace of mind. That’s the legacy behind every neatly streaked plate: attention to detail, clear communication, and a willingness to tune things instead of settling for guesswork.
| Names | |
| Preferred IUPAC name | Disulfato;(1R,2R,3S,4R,6R)-4,6-diamino-2-[(1S,2S,3R,4S,6R)-4-amino-3-[(2R,3R,6S)-3-amino-6-(methylamino)tetrahydro-2H-pyran-2-yl]oxy-2-hydroxycyclohexyl]oxycyclohexan-3-ol |
| Other names |
Kanamycin sulfate Kanamycin monosulfate Kanamycin disulphate Kanamycin A disulfate Kantrex disulfate Kanamycinum disulfuricum |
| Pronunciation | /ˌkæn.əˈmaɪ.sɪn ˈdaɪ.səl.feɪt/ |
| Identifiers | |
| CAS Number | 25389-94-0 |
| Beilstein Reference | 3589574 |
| ChEBI | CHEBI:6105 |
| ChEMBL | CHEMBL509353 |
| ChemSpider | 14115513 |
| DrugBank | DB01172 |
| ECHA InfoCard | 03d804876b |
| EC Number | EC 232-503-8 |
| Gmelin Reference | 95811 |
| KEGG | C00337 |
| MeSH | D003909 |
| PubChem CID | 40965 |
| RTECS number | RQ6300000 |
| UNII | LA9DTA9A0F |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C18H36N4O11S2 |
| Molar mass | = 582.70 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.37 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -6.7 |
| Acidity (pKa) | 7.2 |
| Basicity (pKb) | 7.3 |
| Magnetic susceptibility (χ) | -56.5×10⁻⁶ cm³/mol |
| Viscosity | Viscous liquid |
| Dipole moment | 0 D |
| Pharmacology | |
| ATC code | J01GB04 |
| Hazards | |
| Main hazards | May cause allergic skin reaction, eye irritation, respiratory irritation, and is harmful if swallowed or inhaled |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H319: Causes serious eye irritation. |
| Precautionary statements | P261, P264, P271, P272, P273, P280, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P332+P313, P337+P313, P362+P364, P391, P403+P233, P405, P501 |
| Lethal dose or concentration | LD50 Oral Mouse 4,000 mg/kg |
| LD50 (median dose) | LD50, Mouse: 3600 mg/kg |
| NIOSH | RN: 25389-94-0 |
| PEL (Permissible) | PEL: 5 mg/m³ |
| REL (Recommended) | 50 mg/L |
| IDLH (Immediate danger) | Unknown |
| Related compounds | |
| Related compounds |
Kanamycin A Kanamycin B Kanamycin C Neomycin Gentamicin Amikacin |
